[Abstract Only] Randomized Trial: Ultra-hypofractionated vs. Conventionally Fractionated Radiotherapy for Prostate Cancer
30 Jun, 2019 | 17:18h | UTCUltra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Related Commentary on Twitter
NEW Research—Ultra-hypofractionated versus conventionally fractionated radiotherapy for #prostatecancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial https://t.co/7weB2Qz3wc pic.twitter.com/mSUvbQHMdw
— The Lancet (@TheLancet) June 20, 2019